{"entity":{"type":"insider","cik":"0001324734","url":"/insider/0001324734","json_url":"/insider/0001324734.json","name":"Drechsler Andrew T","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":6,"first":"2006-02-02","last":"2020-09-02","span_basis":"filed_date"},"name_variants":[{"name":"Drechsler Andrew T","source":"filing","n_filings":6,"first_seen":"2006-02-02","last_seen":"2020-09-02"}],"transactions":[{"id":2710865,"accession":"0001493152-20-017159","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-20-017159","line_url":"/filing/0001493152-20-017159#line-1","is_derivative":false,"issuer_cik":"0001324734","issuer_name":"Provention Bio, Inc.","issuer_ticker":"PRVB","issuer_name_source":null,"issuer_url":"/issuer/0001324734","owner_cik":"0001324734","owner_name":"Drechsler Andrew T","owner_display_name":"Drechsler Andrew T","owner_url":"/insider/0001324734","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":11.72,"price_display":"11.72","price_state":"stated","total_value":23440.0,"total_display":"23,440.00","total_whole":"23,440","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-02","filed_date":"2020-09-02","scope":"insider"},{"id":2990796,"accession":"0001493152-20-015601","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-20-015601","line_url":"/filing/0001493152-20-015601#line-1","is_derivative":false,"issuer_cik":"0001324734","issuer_name":"Provention Bio, Inc.","issuer_ticker":"PRVB","issuer_name_source":null,"issuer_url":"/issuer/0001324734","owner_cik":"0001324734","owner_name":"Drechsler Andrew T","owner_display_name":"Drechsler Andrew T","owner_url":"/insider/0001324734","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1750.0,"shares_display":"1,750","price_per_share":13.01,"price_display":"13.01","price_state":"stated","total_value":22767.5,"total_display":"22,767.50","total_whole":"22,768","shares_owned_after":18000.0,"shares_owned_after_display":"18,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-13","filed_date":"2020-08-13","scope":"insider"},{"id":6448046,"accession":"0001493152-18-010233","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-18-010233","line_url":"/filing/0001493152-18-010233#line-1","is_derivative":false,"issuer_cik":"0001324734","issuer_name":"Provention Bio, Inc.","issuer_ticker":"PRVB","issuer_name_source":null,"issuer_url":"/issuer/0001324734","owner_cik":"0001324734","owner_name":"Drechsler Andrew T","owner_display_name":"Drechsler Andrew T","owner_url":"/insider/0001324734","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6250.0,"shares_display":"6,250","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":25000.0,"total_display":"25,000.00","total_whole":"25,000","shares_owned_after":6250.0,"shares_owned_after_display":"6,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-19","filed_date":"2018-07-19","scope":"insider"},{"id":4227363,"accession":"0001127430-17-000017","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127430-17-000017","line_url":"/filing/0001127430-17-000017#line-3","is_derivative":false,"issuer_cik":"0001104506","issuer_name":"INSMED Inc","issuer_ticker":"INSM","issuer_name_source":null,"issuer_url":"/issuer/0001104506","owner_cik":"0001324734","owner_name":"Drechsler Andrew T","owner_display_name":"Drechsler Andrew T","owner_url":"/insider/0001324734","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":16.51,"price_display":"16.51","price_state":"stated","total_value":330200.0,"total_display":"330,200.00","total_whole":"330,200","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-01","filed_date":"2017-03-03","scope":"insider"},{"id":3111534,"accession":"0001127430-16-000158","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127430-16-000158","line_url":"/filing/0001127430-16-000158","is_derivative":false,"issuer_cik":"0001104506","issuer_name":"INSMED Inc","issuer_ticker":"INSM","issuer_name_source":null,"issuer_url":"/issuer/0001104506","owner_cik":"0001324734","owner_name":"Drechsler Andrew T","owner_display_name":"Drechsler Andrew T","owner_url":"/insider/0001324734","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45000.0,"shares_display":"45,000","price_per_share":14.67,"price_display":"14.67","price_state":"stated","total_value":660150.0,"total_display":"660,150.00","total_whole":"660,150","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-14","filed_date":"2016-11-15","scope":"insider","n_lines":2},{"id":5277028,"accession":"0001192482-06-000053","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-06-000053","line_url":"/filing/0001192482-06-000053#line-1","is_derivative":false,"issuer_cik":"0001305409","issuer_name":"Valera Pharmaceuticals Inc","issuer_ticker":"VLRX","issuer_name_source":null,"issuer_url":"/issuer/0001305409","owner_cik":"0001324734","owner_name":"Drechsler Andrew T","owner_display_name":"Drechsler Andrew T","owner_url":"/insider/0001324734","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1600.0,"shares_display":"1,600","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":14400.0,"total_display":"14,400.00","total_whole":"14,400","shares_owned_after":1600.0,"shares_owned_after_display":"1,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-02-02","filed_date":"2006-02-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001695357","name":"Provention Bio, Inc.","url":"/issuer/0001695357","role":"Officer (Chief Financial Officer)","n_filings":3,"first_seen":"2018-07-19","last_seen":"2020-09-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001104506","name":"INSMED Inc","url":"/issuer/0001104506","role":"Officer (Chief Financial Officer)","n_filings":2,"first_seen":"2016-11-15","last_seen":"2017-03-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001305409","name":"Valera Pharmaceuticals Inc","url":"/issuer/0001305409","role":"Officer (Chief Financial Officer)","n_filings":1,"first_seen":"2006-02-02","last_seen":"2006-02-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001324734","retrieved_at":"2026-08-25T00:54:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}